Surgere
PrivateLast Round
Private Equity
Jan 18, 2022
Company Overview
Surgere is an industrial technology company that provides IoT-based supply chain visibility and asset management software and hardware solutions.
Sector
Frontier & Industrial Tech
Verticals
Supply Chain Tracking, IoT Hardware, Logistics Software, Smart Manufacturing
Business Model
B2B
Customer Profile
Hardware + Subscription, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Surgere Comparables
Compare Surgere with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cognosos | 81% | |
| SmartX Technology | 79% | |
| Menasha Corporation | 77% | |
Surgere Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Jan 18, 2022 | ||||
| Debt | Nov 19, 2018 |
Key People
Founding team and executive leadership
Surgere Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cypress Growth Capital | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 28, 2024
Monthly visitors increased 42% MoM, reaching 7.8K.
Surgere Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Surgere's valuation, stock price, and market status.